Saturday 19 June 2021
- Advertisement -

Government signs deal for 30 crore doses of 2nd indigenous vaccine

The arrangement with Biological-E is part of an endeavour of government to encourage indigenous vaccine manufacturers with support

Government has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crore of Covid-19 vaccine doses. Biological-E will manufacture and stockpile these vaccine doses August-December 2021 onwards. 

For the purpose, the Union Ministry of Health and Family Welfare will make an advance payment of Rs 1500 crore to Biological-E. 

The Covid-19 vaccine of Biological-E is currently undergoing Phase III clinical trial after showing promising results in Phase I and II clinical trials. The Biological-E vaccine is a RBD protein sub-unit vaccine and is likely to be available in the next few months. 

The National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) examined and recommended the proposal of Biological-E for approval following due diligence. 

The arrangement with Biological-E is part of the wider endeavour of government to encourage indigenous vaccine manufacturers by providing them support in Research & Development (R&D) and financial support.  

The government has supported Biological-E Covid-19 vaccine candidate from the pre-clinical stage to Phase III studies. The Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 crore but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

This has been undertaken as part of government’s ‘Mission Covid-19 Suraksha ― the Indian Covid-19 Vaccine Development Mission’, which was launched to reinforce and accelerate Covid-19 vaccine development efforts as part of the third stimulus package, Atmanirbhar 3.0.

The mission aims to bring to the citizens a safe, efficacious, affordable and accessible Covid-19 vaccine. The mission is supporting development of 5-6 Covid-19 vaccine candidates. Some of these are now closer to licensure and introduction in public health systems. It has not just accelerated Covid-19 Vaccine development efforts, but fostered a robust end-to-end vaccine development ecosystem in the country that will be available for other on-going and future research and developmental activities for other vaccines.

Publishing partner: Uprising

Sirf News needs to recruit journalists in large numbers to increase the volume of news stories. Please help us pay them by donating. Click on the button below to contribute.

Sirf News is now on Telegram as well. Click on the button below to join our channel (@sirfnewsdotcom) and stay updated with our unique approach to news

Chat with the editor via Messenger

Related Articles

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Stay Connected

- Advertisement -

Latest Articles

Translate »
%d bloggers like this: